| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |